TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
DNA Development i Stockholm AB
Closing information (x1000 EUR)
| Closing information | 2024/08 | 2023/08 | 2022/08 |
| Turnover |
146
|
236 | |
| Financial expenses |
10
|
11 | |
| Earnings before taxes |
24
|
100 | |
| EBITDA |
24
|
111 | |
| Total assets |
215
|
251 | |
| Current assets |
131
|
117 | |
| Current liabilities |
21
|
36 | |
| Equity capital |
186
|
206 | |
| - share capital |
4
|
5 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Solvency |
86.5%
|
82.1% | |
| Turnover per employee |
146
|
236 | |
| Profit as a percentage of turnover |
16.4%
|
42.4% | |
| Return on assets (ROA) |
15.8%
|
44.2% | |
| Current ratio |
623.8%
|
325.0% | |
| Return on equity (ROE) |
12.9%
|
48.5% | |
| Change turnover |
-66
|
146 | |
| Change turnover % |
-29%
|
-31%
|
162% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.